Antioxidants as Therapy for Parkinson's Disease
- 1 May 2005
- journal article
- review article
- Published by SAGE Publications in Antioxidants & Redox Signaling
- Vol. 7 (5-6) , 694-700
Abstract
No abstract availableThis publication has 70 references indexed in Scilit:
- Assessment of neuroimaging techniques as biomarkers of the progression of Parkinson's diseaseExperimental Neurology, 2003
- Protective effect of melatonin in a chronic experimental model of Parkinson’s diseaseBrain Research, 2002
- Neuroprotective effects of pramipexole in young and aged MPTP-treated miceBrain Research, 2001
- Diagnostic and therapeutic applications of azulenyl nitrone spin trapsCellular and Molecular Life Sciences, 1999
- Polyphenols: Chemistry, Dietary Sources, Metabolism, and Nutritional SignificanceNutrition Reviews, 1998
- Coenzyme Q10 attenuates the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) induced loss of striatal dopamine and dopaminergic axons in aged miceBrain Research, 1998
- Oxidative DNA Damage in the Parkinsonian Brain: An Apparent Selective Increase in 8‐Hydroxyguanine Levels in Substantia NigraJournal of Neurochemistry, 1997
- A Generalised Increase in Protein Carbonyls in the Brain in Parkinson's but Not Incidental Lewy Body DiseaseJournal of Neurochemistry, 1997
- Peroxynitrite versus Hydroxyl Radical: The Role of Nitric Oxide in Superoxide‐Dependent Cerebral InjuryaAnnals of the New York Academy of Sciences, 1994
- Vitamin E attenuates the toxic effects of intrastriatal injection of 6-hydroxydopamine (6-OHDA) in rats: Behavioral and biochemical evidenceBrain Research, 1989